207 related articles for article (PubMed ID: 35712672)
1. The Role of DOT1L in Normal and Malignant Hematopoiesis.
Arnold O; Barbosa K; Deshpande AJ; Zhu N
Front Cell Dev Biol; 2022; 10():917125. PubMed ID: 35712672
[TBL] [Abstract][Full Text] [Related]
2. The diverse functions of Dot1 and H3K79 methylation.
Nguyen AT; Zhang Y
Genes Dev; 2011 Jul; 25(13):1345-58. PubMed ID: 21724828
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of DOT1L in leukemia and normal development.
McLean CM; Karemaker ID; van Leeuwen F
Leukemia; 2014 Nov; 28(11):2131-8. PubMed ID: 24854991
[TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle.
Kim W; Choi M; Kim JE
Cell Cycle; 2014; 13(5):726-38. PubMed ID: 24526115
[TBL] [Abstract][Full Text] [Related]
5. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure.
Jones B; Su H; Bhat A; Lei H; Bajko J; Hevi S; Baltus GA; Kadam S; Zhai H; Valdez R; Gonzalo S; Zhang Y; Li E; Chen T
PLoS Genet; 2008 Sep; 4(9):e1000190. PubMed ID: 18787701
[TBL] [Abstract][Full Text] [Related]
6. DOT1L and H3K79 Methylation in Transcription and Genomic Stability.
Wood K; Tellier M; Murphy S
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29495487
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia.
Wang F; Ngo J; Li Y; Liu H; Chen CH; Saifudeen Z; Sequeira-Lopez MLS; El-Dahr SS
Epigenetics; 2021 Nov; 16(11):1235-1250. PubMed ID: 33315499
[TBL] [Abstract][Full Text] [Related]
8. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
9. The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.
Wong M; Polly P; Liu T
Am J Cancer Res; 2015; 5(9):2823-37. PubMed ID: 26609488
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation.
Kim W; Kim R; Park G; Park JW; Kim JE
J Biol Chem; 2012 Feb; 287(8):5588-99. PubMed ID: 22190683
[TBL] [Abstract][Full Text] [Related]
11. Histone methyltransferase Dot1L plays a role in postembryonic development in Xenopus tropicalis.
Wen L; Fu L; Guo X; Chen Y; Shi YB
FASEB J; 2015 Feb; 29(2):385-93. PubMed ID: 25366346
[TBL] [Abstract][Full Text] [Related]
12. The many faces of histone H3K79 methylation.
Farooq Z; Banday S; Pandita TK; Altaf M
Mutat Res Rev Mutat Res; 2016; 768():46-52. PubMed ID: 27234562
[TBL] [Abstract][Full Text] [Related]
13. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.
Chen CW; Armstrong SA
Exp Hematol; 2015 Aug; 43(8):673-84. PubMed ID: 26118503
[TBL] [Abstract][Full Text] [Related]
14. Proline-directed yeast and human MAP kinases phosphorylate the Dot1p/DOT1L histone H3K79 methyltransferase.
Separovich RJ; Karakatsanis NM; Gao K; Fuh D; Hamey JJ; Wilkins MR
FEBS J; 2024 Jan; ():. PubMed ID: 38270553
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
16. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.
Jo SY; Granowicz EM; Maillard I; Thomas D; Hess JL
Blood; 2011 May; 117(18):4759-68. PubMed ID: 21398221
[TBL] [Abstract][Full Text] [Related]
17. Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
Wang X; Wang H; Xu B; Jiang D; Huang S; Yu H; Wu Z; Wu Q
Am J Transl Res; 2019; 11(2):1145-1153. PubMed ID: 30899413
[TBL] [Abstract][Full Text] [Related]
18. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
Steger DJ; Lefterova MI; Ying L; Stonestrom AJ; Schupp M; Zhuo D; Vakoc AL; Kim JE; Chen J; Lazar MA; Blobel GA; Vakoc CR
Mol Cell Biol; 2008 Apr; 28(8):2825-39. PubMed ID: 18285465
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
20. Primitive Erythropoiesis in the Mouse is Independent of DOT1L Methyltransferase Activity.
Malcom CA; Ratri A; Piasecka-Srader J; Borosha S; Chakravarthi VP; Alvarez NS; Vivian JL; Fields TA; Karim Rumi MA; Fields PE
Front Cell Dev Biol; 2021; 9():813503. PubMed ID: 35111761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
